|
Application Number
|
201710886050
|
Application Date
|
2012.03.28
|
|
Publication Number
|
107652283A
|
Publication Date
|
2018.02.02
|
|
Priority Information
|
2011.03.28 US 61/468,163
|
|
International
Classification
|
C07D471/04;A61K31/437;A61K31/5377;A61K31/496;A61P3/06;A61P9/12;A61P3/04;A61K8/49;A61Q19/00;A23L33/165
|
|
|
Applicant(s) Name
|
SJT MOLECULAR RESEARCH, S.L.
|
|
|
Address
|
|
|
|
Inventor(s) Name
|
AGREDA NAVAJAS JUAN CARLOS;MIKIO KASSUYA ROBERTO
|
|
|
Patent Agency Code
|
11021
|
Patent Agent
|
Wu Shengzhou
|
|
AbstractPresent invention refers to new compounds of formula I or II, its synthesis and its use in the treatment of metabolic syndrome, particularly for the treatment of type I or type II diabetes and/or metabolic syndrome or metabolic disease or metabolic disorders.
|
|